These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 16171574)

  • 1. Discordant plasma and cerebral spinal fluid cytokines/chemokines in relation to HIV-1-associated dementia.
    Killebrew DA; Troelstrup D; Valcour V; Williams A; Aguon J; Sapalo D; Shikuma C; Ratto-Kim S; Shiramizu B
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51 Suppl():OL745-54. PubMed ID: 16171574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique monocyte subset in patients with AIDS dementia.
    Pulliam L; Gascon R; Stubblebine M; McGuire D; McGrath MS
    Lancet; 1997 Mar; 349(9053):692-5. PubMed ID: 9078201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection.
    Kamat A; Lyons JL; Misra V; Uno H; Morgello S; Singer EJ; Gabuzda D
    J Acquir Immune Defic Syndr; 2012 Jul; 60(3):234-43. PubMed ID: 22569268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia.
    Kelder W; McArthur JC; Nance-Sproson T; McClernon D; Griffin DE
    Ann Neurol; 1998 Nov; 44(5):831-5. PubMed ID: 9818943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia.
    Conant K; Garzino-Demo A; Nath A; McArthur JC; Halliday W; Power C; Gallo RC; Major EO
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3117-21. PubMed ID: 9501225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive chronic inflammatory monocyte phenotype in subjects with high HIV-1 viral load.
    Pulliam L; Sun B; Rempel H
    J Neuroimmunol; 2004 Dec; 157(1-2):93-8. PubMed ID: 15579285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokines and receptors in HIV encephalitis.
    Sanders VJ; Pittman CA; White MG; Wang G; Wiley CA; Achim CL
    AIDS; 1998 Jun; 12(9):1021-6. PubMed ID: 9662198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1.
    Letendre SL; Lanier ER; McCutchan JA
    J Infect Dis; 1999 Aug; 180(2):310-9. PubMed ID: 10395844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is repetitive opportunistic infection in AIDS patients the effective mechanism for neurodegeneration in terms of endlessly amplifying cytokine/chemokine effect?
    Agius LM
    Med Hypotheses; 2004; 62(4):587-92. PubMed ID: 15050112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different plasma levels of interleukins and chemokines: comparison between children and adults with AIDS in China.
    Jin CZ; Zhao Y; Zhang FJ; Yao HP; Wu LJ; Zhao HX; Wei HS; Wu NP
    Chin Med J (Engl); 2009 Mar; 122(5):530-5. PubMed ID: 19323903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophages, chemokines and neuronal injury in HIV-1-associated dementia.
    Ryan LA; Cotter RL; Zink WE; Gendelman HE; Zheng J
    Cell Mol Biol (Noisy-le-grand); 2002 Mar; 48(2):137-50. PubMed ID: 11995633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective and anti-human immunodeficiency virus activity of minocycline.
    Zink MC; Uhrlaub J; DeWitt J; Voelker T; Bullock B; Mankowski J; Tarwater P; Clements J; Barber S
    JAMA; 2005 Apr; 293(16):2003-11. PubMed ID: 15855434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis.
    Sasseville VG; Smith MM; Mackay CR; Pauley DR; Mansfield KG; Ringler DJ; Lackner AA
    Am J Pathol; 1996 Nov; 149(5):1459-67. PubMed ID: 8909235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 RNA levels in cerebrospinal fluid and plasma correlate with AIDS dementia.
    Hengge UR; Brockmeyer NH; Esser S; Maschke M; Goos M
    AIDS; 1998 May; 12(7):818-20. PubMed ID: 9619817
    [No Abstract]   [Full Text] [Related]  

  • 15. A potential role for interferon-alpha in the pathogenesis of HIV-associated dementia.
    Rho MB; Wesselingh S; Glass JD; McArthur JC; Choi S; Griffin J; Tyor WR
    Brain Behav Immun; 1995 Dec; 9(4):366-77. PubMed ID: 8903853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes.
    Weiss JM; Nath A; Major EO; Berman JW
    J Immunol; 1999 Sep; 163(5):2953-9. PubMed ID: 10453044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potential antibody markers in HIV-associated dementia.
    Schutzer SE; Berger JR; Brunner M
    J Neuroimmunol; 2004 Dec; 157(1-2):120-5. PubMed ID: 15579288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta-1 and interferon-alpha in the AIDS dementia complex (ADC): possible relationship with cerebral viral load?
    Perrella O; Carreiri PB; Perrella A; Sbreglia C; Gorga F; Guarnaccia D; Tarantino G
    Eur Cytokine Netw; 2001 Mar; 12(1):51-5. PubMed ID: 11282546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GM-CSF and M-CSF modulate beta-chemokine and HIV-1 expression in microglia.
    Si Q; Cosenza M; Zhao ML; Goldstein H; Lee SC
    Glia; 2002 Aug; 39(2):174-83. PubMed ID: 12112368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.